<?xml version="1.0" encoding="UTF-8"?><safetyreport>
		<safetyreportversion>1</safetyreportversion>
		<safetyreportid>JP-MLMSERVICE-TESTCASE-20150427-40</safetyreportid>
		<primarysourcecountry>JP</primarysourcecountry>
		<occurcountry>JP</occurcountry>
		<transmissiondateformat>102</transmissiondateformat>
		<transmissiondate>20150215</transmissiondate>
		<reporttype>1</reporttype>
		<serious>1</serious>
		<seriousnessdeath>2</seriousnessdeath>
		<seriousnesslifethreatening>2</seriousnesslifethreatening>
		<seriousnesshospitalization>1</seriousnesshospitalization>
		<seriousnessdisabling>2</seriousnessdisabling>
		<seriousnesscongenitalanomali>2</seriousnesscongenitalanomali>
		<seriousnessother>2</seriousnessother>
		<receivedateformat>102</receivedateformat>
		<receivedate>20150206</receivedate>
		<receiptdateformat>102</receiptdateformat>
		<receiptdate>20150206</receiptdate>
		<additionaldocument>2</additionaldocument>
		<documentlist/>
		<fulfillexpeditecriteria>1</fulfillexpeditecriteria>
		<authoritynumb/>
		<companynumb>JP-MLMSERVICE-TESTCASE-20150427-40</companynumb>
		<duplicate/>
		<casenullification/>
		<nullificationreason/>
		<medicallyconfirm/>
		<primarysource>
			<reportertitle/>
			<reportergivename>Takayuki</reportergivename>
			<reportermiddlename/>
			<reporterfamilyname>Hoshina</reporterfamilyname>
			<reporterorganization>Graduate School of Medical Sciences</reporterorganization>
			<reporterdepartment>Department of Pediatrics</reporterdepartment>
			<reporterstreet>Kyushu University3-1-1 Maidashi</reporterstreet>
			<reportercity>Higashi-ku</reportercity>
			<reporterstate>Fukuoka</reporterstate>
			<reporterpostcode>812-8582</reporterpostcode>
			<reportercountry>JP</reportercountry>
			<qualification>3</qualification>
			<literaturereference>Nanishi E, Hoshina T, Ohga S, Nishio H, Hara T. Drug reaction with eosinophilia and systemic symptoms during primary EpsteineBarr virus infection. Journal of Microbiology, Immunology and Infection. 2015;48:109-112</literaturereference>
			<studyname/>
			<sponsorstudynumb/>
			<observestudytype/>
		</primarysource>
		<sender>
			<sendertype>6</sendertype>
			<senderorganization>MLMSERVICE</senderorganization>
			<senderdepartment>test</senderdepartment>
			<sendertitle>dr</sendertitle>
			<sendergivename>mlmtest</sendergivename>
			<sendermiddlename/>
			<senderfamilyname>test</senderfamilyname>
			<senderstreetaddress>test</senderstreetaddress>
			<sendercity>test</sendercity>
			<senderstate/>
			<senderpostcode>1</senderpostcode>
			<sendercountrycode>GB</sendercountrycode>
			<sendertel>12345</sendertel>
			<sendertelextension>3456</sendertelextension>
			<sendertelcountrycode>44</sendertelcountrycode>
			<senderfax>12345</senderfax>
			<senderfaxextension>3456</senderfaxextension>
			<senderfaxcountrycode>44</senderfaxcountrycode>
			<senderemailaddress>1@MLMSERVICE.com</senderemailaddress>
		</sender>
		<receiver>
			<receivertype/>
			<receiverorganization>EVTEST</receiverorganization>
			<receiverdepartment/>
			<receivertitle/>
			<receivergivename/>
			<receivermiddlename/>
			<receiverfamilyname/>
			<receiverstreetaddress/>
			<receivercity/>
			<receiverstate/>
			<receiverpostcode/>
			<receivercountrycode/>
			<receivertel/>
			<receivertelextension/>
			<receivertelcountrycode/>
			<receiverfax/>
			<receiverfaxextension/>
			<receiverfaxcountrycode/>
			<receiveremailaddress/>
		</receiver>
		<patient>
			<patientinitial>PRIVACY</patientinitial>
			<patientgpmedicalrecordnumb/>
			<patientspecialistrecordnumb/>
			<patienthospitalrecordnumb/>
			<patientinvestigationnumb/>
			<patientbirthdateformat/>
			<patientbirthdate/>
			<patientonsetage>4</patientonsetage>
			<patientonsetageunit>801</patientonsetageunit>
			<gestationperiod/>
			<gestationperiodunit/>
			<patientagegroup/>
			<patientweight/>
			<patientheight/>
			<patientsex>1</patientsex>
			<lastmenstrualdateformat/>
			<patientlastmenstrualdate/>
			<patientmedicalhistorytext/>
			<resultstestsprocedures/>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>17.1</patientepisodenamemeddraversion>
				<patientepisodename>10015108</patientepisodename>
				<patientmedicalstartdateformat/>
				<patientmedicalstartdate/>
				<patientmedicalcontinue>1</patientmedicalcontinue>
				<patientmedicalenddateformat/>
				<patientmedicalenddate/>
				<patientmedicalcomment/>
			</medicalhistoryepisode>
			<reaction>
				<primarysourcereaction>Abdominal pain emerged</primarysourcereaction>
				<reactionmeddraversionllt>17.1</reactionmeddraversionllt>
				<reactionmeddrallt>10000081</reactionmeddrallt>
				<reactionmeddraversionpt/>
				<reactionmeddrapt/>
				<termhighlighted>3</termhighlighted>
				<reactionstartdateformat/>
				<reactionstartdate/>
				<reactionenddateformat/>
				<reactionenddate/>
				<reactionduration/>
				<reactiondurationunit/>
				<reactionfirsttime/>
				<reactionfirsttimeunit/>
				<reactionlasttime/>
				<reactionlasttimeunit/>
				<reactionoutcome>1</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Body temperature was 38.0 degree centigrade/prolonged fever</primarysourcereaction>
				<reactionmeddraversionllt>17.1</reactionmeddraversionllt>
				<reactionmeddrallt>10073718</reactionmeddrallt>
				<reactionmeddraversionpt/>
				<reactionmeddrapt/>
				<termhighlighted>3</termhighlighted>
				<reactionstartdateformat/>
				<reactionstartdate/>
				<reactionenddateformat/>
				<reactionenddate/>
				<reactionduration/>
				<reactiondurationunit/>
				<reactionfirsttime/>
				<reactionfirsttimeunit/>
				<reactionlasttime/>
				<reactionlasttimeunit/>
				<reactionoutcome>1</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Cervical lymphadenopathy</primarysourcereaction>
				<reactionmeddraversionllt>17.1</reactionmeddraversionllt>
				<reactionmeddrallt>10025200</reactionmeddrallt>
				<reactionmeddraversionpt/>
				<reactionmeddrapt/>
				<termhighlighted>3</termhighlighted>
				<reactionstartdateformat/>
				<reactionstartdate/>
				<reactionenddateformat/>
				<reactionenddate/>
				<reactionduration/>
				<reactiondurationunit/>
				<reactionfirsttime/>
				<reactionfirsttimeunit/>
				<reactionlasttime/>
				<reactionlasttimeunit/>
				<reactionoutcome>1</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Drug reaction with eosinophilia and systemic symptoms</primarysourcereaction>
				<reactionmeddraversionllt>17.1</reactionmeddraversionllt>
				<reactionmeddrallt>10058899</reactionmeddrallt>
				<reactionmeddraversionpt/>
				<reactionmeddrapt/>
				<termhighlighted>3</termhighlighted>
				<reactionstartdateformat/>
				<reactionstartdate/>
				<reactionenddateformat/>
				<reactionenddate/>
				<reactionduration/>
				<reactiondurationunit/>
				<reactionfirsttime/>
				<reactionfirsttimeunit/>
				<reactionlasttime/>
				<reactionlasttimeunit/>
				<reactionoutcome>1</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Generalized skin rash/Generalized skin eruption</primarysourcereaction>
				<reactionmeddraversionllt>17.1</reactionmeddraversionllt>
				<reactionmeddrallt>10037858</reactionmeddrallt>
				<reactionmeddraversionpt/>
				<reactionmeddrapt/>
				<termhighlighted>3</termhighlighted>
				<reactionstartdateformat/>
				<reactionstartdate/>
				<reactionenddateformat/>
				<reactionenddate/>
				<reactionduration/>
				<reactiondurationunit/>
				<reactionfirsttime/>
				<reactionfirsttimeunit/>
				<reactionlasttime/>
				<reactionlasttimeunit/>
				<reactionoutcome>1</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Hepatomegaly</primarysourcereaction>
				<reactionmeddraversionllt>17.1</reactionmeddraversionllt>
				<reactionmeddrallt>10019842</reactionmeddrallt>
				<reactionmeddraversionpt/>
				<reactionmeddrapt/>
				<termhighlighted>3</termhighlighted>
				<reactionstartdateformat/>
				<reactionstartdate/>
				<reactionenddateformat/>
				<reactionenddate/>
				<reactionduration/>
				<reactiondurationunit/>
				<reactionfirsttime/>
				<reactionfirsttimeunit/>
				<reactionlasttime/>
				<reactionlasttimeunit/>
				<reactionoutcome>1</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Jaundice</primarysourcereaction>
				<reactionmeddraversionllt>17.1</reactionmeddraversionllt>
				<reactionmeddrallt>10023126</reactionmeddrallt>
				<reactionmeddraversionpt/>
				<reactionmeddrapt/>
				<termhighlighted>3</termhighlighted>
				<reactionstartdateformat/>
				<reactionstartdate/>
				<reactionenddateformat/>
				<reactionenddate/>
				<reactionduration/>
				<reactiondurationunit/>
				<reactionfirsttime/>
				<reactionfirsttimeunit/>
				<reactionlasttime/>
				<reactionlasttimeunit/>
				<reactionoutcome>1</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Pruritic maculopapular eruption and generalized skin rash</primarysourcereaction>
				<reactionmeddraversionllt>17.1</reactionmeddraversionllt>
				<reactionmeddrallt>10025422</reactionmeddrallt>
				<reactionmeddraversionpt/>
				<reactionmeddrapt/>
				<termhighlighted>3</termhighlighted>
				<reactionstartdateformat/>
				<reactionstartdate/>
				<reactionenddateformat/>
				<reactionenddate/>
				<reactionduration/>
				<reactiondurationunit/>
				<reactionfirsttime/>
				<reactionfirsttimeunit/>
				<reactionlasttime/>
				<reactionlasttimeunit/>
				<reactionoutcome>1</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Pruritic maculopapular eruption/generalized skin rash</primarysourcereaction>
				<reactionmeddraversionllt>17.1</reactionmeddraversionllt>
				<reactionmeddrallt>10037884</reactionmeddrallt>
				<reactionmeddraversionpt/>
				<reactionmeddrapt/>
				<termhighlighted>3</termhighlighted>
				<reactionstartdateformat/>
				<reactionstartdate/>
				<reactionenddateformat/>
				<reactionenddate/>
				<reactionduration/>
				<reactiondurationunit/>
				<reactionfirsttime/>
				<reactionfirsttimeunit/>
				<reactionlasttime/>
				<reactionlasttimeunit/>
				<reactionoutcome>1</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Skin and bulbar conjunctiva were icteric</primarysourcereaction>
				<reactionmeddraversionllt>17.1</reactionmeddraversionllt>
				<reactionmeddrallt>10021206</reactionmeddrallt>
				<reactionmeddraversionpt/>
				<reactionmeddrapt/>
				<termhighlighted>3</termhighlighted>
				<reactionstartdateformat/>
				<reactionstartdate/>
				<reactionenddateformat/>
				<reactionenddate/>
				<reactionduration/>
				<reactiondurationunit/>
				<reactionfirsttime/>
				<reactionfirsttimeunit/>
				<reactionlasttime/>
				<reactionlasttimeunit/>
				<reactionoutcome>1</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Skin and bulbar conjunctiva were icteric</primarysourcereaction>
				<reactionmeddraversionllt>17.1</reactionmeddraversionllt>
				<reactionmeddrallt>10048245</reactionmeddrallt>
				<reactionmeddraversionpt/>
				<reactionmeddrapt/>
				<termhighlighted>3</termhighlighted>
				<reactionstartdateformat/>
				<reactionstartdate/>
				<reactionenddateformat/>
				<reactionenddate/>
				<reactionduration/>
				<reactiondurationunit/>
				<reactionfirsttime/>
				<reactionfirsttimeunit/>
				<reactionlasttime/>
				<reactionlasttimeunit/>
				<reactionoutcome>1</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Slight neutropenia</primarysourcereaction>
				<reactionmeddraversionllt>17.1</reactionmeddraversionllt>
				<reactionmeddrallt>10029354</reactionmeddrallt>
				<reactionmeddraversionpt/>
				<reactionmeddrapt/>
				<termhighlighted>3</termhighlighted>
				<reactionstartdateformat/>
				<reactionstartdate/>
				<reactionenddateformat/>
				<reactionenddate/>
				<reactionduration/>
				<reactiondurationunit/>
				<reactionfirsttime/>
				<reactionfirsttimeunit/>
				<reactionlasttime/>
				<reactionlasttimeunit/>
				<reactionoutcome>1</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Thrombocytopenia</primarysourcereaction>
				<reactionmeddraversionllt>17.1</reactionmeddraversionllt>
				<reactionmeddrallt>10043554</reactionmeddrallt>
				<reactionmeddraversionpt/>
				<reactionmeddrapt/>
				<termhighlighted>3</termhighlighted>
				<reactionstartdateformat/>
				<reactionstartdate/>
				<reactionenddateformat/>
				<reactionenddate/>
				<reactionduration/>
				<reactiondurationunit/>
				<reactionfirsttime/>
				<reactionfirsttimeunit/>
				<reactionlasttime/>
				<reactionlasttimeunit/>
				<reactionoutcome>1</reactionoutcome>
			</reaction>
			<test>
				<testdateformat/>
				<testdate/>
				<testname>Alanine aminotransferase</testname>
				<testresult>1777</testresult>
				<testunit>U/l</testunit>
				<lowtestrange/>
				<hightestrange/>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat/>
				<testdate/>
				<testname>Alanine aminotransferase</testname>
				<testresult>894</testresult>
				<testunit>U/l</testunit>
				<lowtestrange/>
				<hightestrange/>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat/>
				<testdate/>
				<testname>Aspartate aminotransferase</testname>
				<testresult>1821</testresult>
				<testunit>U/l</testunit>
				<lowtestrange/>
				<hightestrange/>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat/>
				<testdate/>
				<testname>Aspartate aminotransferase</testname>
				<testresult>570</testresult>
				<testunit>U/l</testunit>
				<lowtestrange/>
				<hightestrange/>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat/>
				<testdate/>
				<testname>Bilirubin conjugated</testname>
				<testresult>5.1</testresult>
				<testunit>mg/dl</testunit>
				<lowtestrange/>
				<hightestrange/>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat/>
				<testdate/>
				<testname>Bilirubin conjugated</testname>
				<testresult>5.6</testresult>
				<testunit>mg/dl</testunit>
				<lowtestrange/>
				<hightestrange/>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat/>
				<testdate/>
				<testname>Bilirubin total</testname>
				<testresult>6.8</testresult>
				<testunit>mg/dl</testunit>
				<lowtestrange/>
				<hightestrange/>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat/>
				<testdate/>
				<testname>Bilirubin total</testname>
				<testresult>7.8</testresult>
				<testunit>mg/dl</testunit>
				<lowtestrange/>
				<hightestrange/>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat/>
				<testdate/>
				<testname>Immunoglobulin E</testname>
				<testresult>Less than 10 U/mL</testresult>
				<testunit>U/l</testunit>
				<lowtestrange/>
				<hightestrange/>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat/>
				<testdate/>
				<testname>Lactate dehydrogenase</testname>
				<testresult>637</testresult>
				<testunit>U/l</testunit>
				<lowtestrange/>
				<hightestrange/>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat/>
				<testdate/>
				<testname>Body temperature</testname>
				<testresult>38.0</testresult>
				<testunit>Â°C</testunit>
				<lowtestrange/>
				<hightestrange/>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat/>
				<testdate/>
				<testname>CD4/CD8 ratio</testname>
				<testresult>0.45</testresult>
				<testunit/>
				<lowtestrange/>
				<hightestrange/>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat/>
				<testdate/>
				<testname>C-reactive protein</testname>
				<testresult>0.09</testresult>
				<testunit>mg/dl</testunit>
				<lowtestrange/>
				<hightestrange/>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat/>
				<testdate/>
				<testname>Gamma glutamyl transpeptidase</testname>
				<testresult>348</testresult>
				<testunit>U/l</testunit>
				<lowtestrange/>
				<hightestrange/>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat/>
				<testdate/>
				<testname>Haemoglobin</testname>
				<testresult>11.7</testresult>
				<testunit>g/dl</testunit>
				<lowtestrange/>
				<hightestrange/>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat/>
				<testdate/>
				<testname>Interleukin-2 receptor assay</testname>
				<testresult>6061</testresult>
				<testunit>U/ml</testunit>
				<lowtestrange/>
				<hightestrange/>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat/>
				<testdate/>
				<testname>Lymphocyte transformation test</testname>
				<testresult>Positive</testresult>
				<testunit/>
				<lowtestrange/>
				<hightestrange/>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat/>
				<testdate/>
				<testname>Platelet count</testname>
				<testresult>143</testresult>
				<testunit>10^9/L</testunit>
				<lowtestrange/>
				<hightestrange/>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat/>
				<testdate/>
				<testname>PCR</testname>
				<testresult>Abnormal</testresult>
				<testunit/>
				<lowtestrange/>
				<hightestrange/>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat/>
				<testdate/>
				<testname>Ferritin</testname>
				<testresult>1492</testresult>
				<testunit>mg/dl</testunit>
				<lowtestrange/>
				<hightestrange/>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat/>
				<testdate/>
				<testname>White blood cell count</testname>
				<testresult>3.99</testresult>
				<testunit>10^9/L</testunit>
				<lowtestrange/>
				<hightestrange/>
				<moreinformation>1</moreinformation>
			</test>
			<drug>
				<drugcharacterization>1</drugcharacterization>
				<medicinalproduct/>
				<obtaindrugcountry>JP</obtaindrugcountry>
				<drugbatchnumb/>
				<drugauthorizationnumb/>
				<drugauthorizationcountry>JP</drugauthorizationcountry>
				<drugauthorizationholder/>
				<drugstructuredosagenumb/>
				<drugstructuredosageunit/>
				<drugseparatedosagenumb/>
				<drugintervaldosageunitnumb/>
				<drugintervaldosagedefinition/>
				<drugcumulativedosagenumb/>
				<drugcumulativedosageunit/>
				<drugdosagetext/>
				<drugdosageform/>
				<drugadministrationroute>54</drugadministrationroute>
				<drugparadministration/>
				<reactiongestationperiod/>
				<reactiongestationperiodunit/>
				<drugindicationmeddraversion>17.1</drugindicationmeddraversion>
				<drugindication>10070592</drugindication>
				<drugstartdateformat/>
				<drugstartdate/>
				<drugstartperiod/>
				<drugstartperiodunit/>
				<druglastperiod/>
				<druglastperiodunit/>
				<drugenddateformat/>
				<drugenddate/>
				<drugtreatmentduration/>
				<drugtreatmentdurationunit/>
				<actiondrug>5</actiondrug>
				<drugrecurreadministration/>
				<drugadditional/>
				<activesubstance>
					<activesubstancename>PARACETAMOL</activesubstancename>
				</activesubstance>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>17.1</drugreactionassesmeddraversion>
					<drugreactionasses>10000081</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>17.1</drugreactionassesmeddraversion>
					<drugreactionasses>10000081</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>17.1</drugreactionassesmeddraversion>
					<drugreactionasses>10019842</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>17.1</drugreactionassesmeddraversion>
					<drugreactionasses>10019842</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>17.1</drugreactionassesmeddraversion>
					<drugreactionasses>10021206</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>17.1</drugreactionassesmeddraversion>
					<drugreactionasses>10021206</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>17.1</drugreactionassesmeddraversion>
					<drugreactionasses>10023126</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>17.1</drugreactionassesmeddraversion>
					<drugreactionasses>10023126</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>17.1</drugreactionassesmeddraversion>
					<drugreactionasses>10025200</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>17.1</drugreactionassesmeddraversion>
					<drugreactionasses>10025200</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>17.1</drugreactionassesmeddraversion>
					<drugreactionasses>10025422</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>17.1</drugreactionassesmeddraversion>
					<drugreactionasses>10025422</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>17.1</drugreactionassesmeddraversion>
					<drugreactionasses>10029354</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>17.1</drugreactionassesmeddraversion>
					<drugreactionasses>10029354</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>17.1</drugreactionassesmeddraversion>
					<drugreactionasses>10037858</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>17.1</drugreactionassesmeddraversion>
					<drugreactionasses>10037858</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>17.1</drugreactionassesmeddraversion>
					<drugreactionasses>10037884</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>17.1</drugreactionassesmeddraversion>
					<drugreactionasses>10037884</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>17.1</drugreactionassesmeddraversion>
					<drugreactionasses>10043554</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>17.1</drugreactionassesmeddraversion>
					<drugreactionasses>10043554</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>17.1</drugreactionassesmeddraversion>
					<drugreactionasses>10048245</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>17.1</drugreactionassesmeddraversion>
					<drugreactionasses>10048245</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>17.1</drugreactionassesmeddraversion>
					<drugreactionasses>10058899</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>17.1</drugreactionassesmeddraversion>
					<drugreactionasses>10058899</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>17.1</drugreactionassesmeddraversion>
					<drugreactionasses>10073718</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>17.1</drugreactionassesmeddraversion>
					<drugreactionasses>10073718</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
			</drug>
			<drug>
				<drugcharacterization>1</drugcharacterization>
				<medicinalproduct/>
				<obtaindrugcountry>JP</obtaindrugcountry>
				<drugbatchnumb/>
				<drugauthorizationnumb/>
				<drugauthorizationcountry>JP</drugauthorizationcountry>
				<drugauthorizationholder/>
				<drugstructuredosagenumb/>
				<drugstructuredosageunit/>
				<drugseparatedosagenumb/>
				<drugintervaldosageunitnumb/>
				<drugintervaldosagedefinition/>
				<drugcumulativedosagenumb/>
				<drugcumulativedosageunit/>
				<drugdosagetext/>
				<drugdosageform/>
				<drugadministrationroute>48</drugadministrationroute>
				<drugparadministration/>
				<reactiongestationperiod/>
				<reactiongestationperiodunit/>
				<drugindicationmeddraversion>17.1</drugindicationmeddraversion>
				<drugindication>10070592</drugindication>
				<drugstartdateformat/>
				<drugstartdate/>
				<drugstartperiod/>
				<drugstartperiodunit/>
				<druglastperiod/>
				<druglastperiodunit/>
				<drugenddateformat/>
				<drugenddate/>
				<drugtreatmentduration/>
				<drugtreatmentdurationunit/>
				<actiondrug>5</actiondrug>
				<drugrecurreadministration/>
				<drugadditional/>
				<activesubstance>
					<activesubstancename>CEFDITOREN PIVOXIL</activesubstancename>
				</activesubstance>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>17.1</drugreactionassesmeddraversion>
					<drugreactionasses>10000081</drugreactionasses>
					<drugassessmentsource>2</drugassessmentsource>
					<drugassessmentmethod>EVCTM</drugassessmentmethod>
					<drugresult>1</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>17.1</drugreactionassesmeddraversion>
					<drugreactionasses>10019842</drugreactionasses>
					<drugassessmentsource>2</drugassessmentsource>
					<drugassessmentmethod>EVCTM</drugassessmentmethod>
					<drugresult>1</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>17.1</drugreactionassesmeddraversion>
					<drugreactionasses>10021206</drugreactionasses>
					<drugassessmentsource>2</drugassessmentsource>
					<drugassessmentmethod>EVCTM</drugassessmentmethod>
					<drugresult>1</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>17.1</drugreactionassesmeddraversion>
					<drugreactionasses>10023126</drugreactionasses>
					<drugassessmentsource>2</drugassessmentsource>
					<drugassessmentmethod>EVCTM</drugassessmentmethod>
					<drugresult>1</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>17.1</drugreactionassesmeddraversion>
					<drugreactionasses>10025200</drugreactionasses>
					<drugassessmentsource>2</drugassessmentsource>
					<drugassessmentmethod>EVCTM</drugassessmentmethod>
					<drugresult>1</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>17.1</drugreactionassesmeddraversion>
					<drugreactionasses>10025422</drugreactionasses>
					<drugassessmentsource>2</drugassessmentsource>
					<drugassessmentmethod>EVCTM</drugassessmentmethod>
					<drugresult>1</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>17.1</drugreactionassesmeddraversion>
					<drugreactionasses>10029354</drugreactionasses>
					<drugassessmentsource>2</drugassessmentsource>
					<drugassessmentmethod>EVCTM</drugassessmentmethod>
					<drugresult>1</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>17.1</drugreactionassesmeddraversion>
					<drugreactionasses>10037858</drugreactionasses>
					<drugassessmentsource>2</drugassessmentsource>
					<drugassessmentmethod>EVCTM</drugassessmentmethod>
					<drugresult>1</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>17.1</drugreactionassesmeddraversion>
					<drugreactionasses>10037884</drugreactionasses>
					<drugassessmentsource>2</drugassessmentsource>
					<drugassessmentmethod>EVCTM</drugassessmentmethod>
					<drugresult>1</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>17.1</drugreactionassesmeddraversion>
					<drugreactionasses>10043554</drugreactionasses>
					<drugassessmentsource>2</drugassessmentsource>
					<drugassessmentmethod>EVCTM</drugassessmentmethod>
					<drugresult>1</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>17.1</drugreactionassesmeddraversion>
					<drugreactionasses>10048245</drugreactionasses>
					<drugassessmentsource>2</drugassessmentsource>
					<drugassessmentmethod>EVCTM</drugassessmentmethod>
					<drugresult>1</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>17.1</drugreactionassesmeddraversion>
					<drugreactionasses>10058899</drugreactionasses>
					<drugassessmentsource>2</drugassessmentsource>
					<drugassessmentmethod>EVCTM</drugassessmentmethod>
					<drugresult>1</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>17.1</drugreactionassesmeddraversion>
					<drugreactionasses>10073718</drugreactionasses>
					<drugassessmentsource>2</drugassessmentsource>
					<drugassessmentmethod>EVCTM</drugassessmentmethod>
					<drugresult>1</drugresult>
				</drugreactionrelatedness>
			</drug>
			<summary>
				<narrativeincludeclinical>Case number PHHY2015JP015840 is an initial literature report received on 06 Feb 2015. The author discussed about drug reaction with eosinophilia and systemic symptoms during primary Epstein-Barr virus infection. This report refers to a 04 year old male patient. The patient had received oral cefditoren-pivoxil (CDTR-PI) and acetaminophen (manufacturer unknown) suppository from the 6th day to the 12th day of illness. Despite the defervescence on the 11th day of illness, jaundice and abdominal pain emerged. On the 13th day of illness, he presented to a practitioner again because of developing generalized skin rash. The patient was admitted to our hospital on the 14th day of illness because of prolonged fever, jaundice, and generalized skin eruption. The laboratory findings showed increased levels of aspartate aminotransferase (AST) at 1821 U/L; alanine aminotransferase (ALT) at 1777 U/L, total bilirubin, 6.8 mg/dL and direct bilirubin at 5.1 mg/dL. He was then referred for further management. On admission, his body temperature was 38.0 degree centigrade. Skin and bulbar conjunctiva were icteric. Pruritic maculopapular eruption spread confluently on the trunk, extremities, palms, and soles. Mucous membranes and conjunctivas were spared. There was cervical lymphadenopathy and hepatomegaly, but no splenomegaly. Complete blood counts showed a leukocyte count of 3.99 X 109/L with 26% segmented neutrophils, 55% lymphocytes, 10% monocytes, 4% eosinophils and 5% atypical lymphocytes, a hemoglobin concentration of 11.7 g/dL and a platelet count of 143 X 109/L. Blood chemistry showed a total bilirubin of 7.8 mg/dL, direct bilirubin of 5.6 mg/dL, AST of 570 U/L, ALT of 894 U/L; lactate dehydrogenase of 637 U/L and g-glutamyl transpeptidase of 348 U/L. C-reactive protein concentration was 0.09 mg/dL. Serum levels of ferritin (1492 mg/dL) and soluble interleukin-2 receptor (6061 U/mL) were both high. Immunoglobulin levels and coagulation studies were unremarkable (immunoglobulin E &lt; 10 U/mL). Surface maker analysis of the peripheral blood lymphocytes showed a reversed CD4/CD8 ratio (0.45) and a prominently increased proportion of activated CD8T cells (72.2%). There were past inactive infections, but no reactivations of cytomegalovirus or HHV-6. Positive antiviral capsid antigen immunoglobulin M with negative anti-EBV nuclear antigen antibody indicated primary EBV infection. A high copy number of EBV-DNA (3 X 106 copies/L of peripheral blood) was detected by real-time polymerase chain reaction. Lymphocyte transformation tests (LTT) for acetaminophen [stimulation index (SI) 555%] or CDTR-PI (SI 314%) was highly positive. The diagnosis of drug reaction with eosinophilia and systemic symptoms (DRESS) was made because the patient fulfilled all but one criteria of eosinophilia. Dexchlorpheniramine and glycyrrhizinate were started with no use of the other drugs including antipyretics. The present patient showed slight neutropenia and thrombocytopenia, but no eosinophilia. In the present patient, the positive result of LTT came to be negative with the favorable clinical course. All symptoms resolved until the cessation of therapy on the 19th day of illness. Negative LTT for acetaminophen (SI 81%) or CDTR-PI (SI 71%) was confirmed two months later. Thereafter, skin eruption did not appear when acetaminophen was administered at the chance of fever. The author commented that LTTs were positive for cefditoren-pivoxil and acetaminophen.</narrativeincludeclinical>
				<reportercomment/>
				<senderdiagnosismeddraversion/>
				<senderdiagnosis/>
				<sendercomment/>
			</summary>
		</patient>
	</safetyreport>